FL S1700

Expands Attorney General access to prescription drug monitoring program records to include active investigations and pending civil or criminal litigation involving prescribed controlled substances, beyond just Medicaid fraud cases.

Requires the Department of Health to assign each patient a unique identifying number when releasing information to the Attorney General, limiting disclosure to only the unique identifier, year of birth, and county/city/zip code of residence.

Authorizes the Attorney General to introduce prescription drug monitoring program records as evidence in civil, criminal, or administrative actions against dispensers or pharmacies, and allows program staff to testify to authenticate such records.

Restricts further disclosure of prescription drug monitoring program information shared with state attorneys or the Attorney General, allowing release only in response to discovery demands directly related to the case, or by court order for unrelated information.